Whereas all BPD cases, independent of disease severity, showed reactive oxygen species (ROS) synthesis, the main differences between mild and more severe BPD cases included the engagement of adaptive immune responses (IL-5) and developmental pathways (WNT1), in line with previous studies (34, 35). This evidence concerns the gene IL5 and bronchopulmonary dysplasia.